U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898203) titled 'Precision Imaging to Evaluate Kaposi Sarcoma' on March 20.
Brief Summary: AIM 1:
In Uganda and Kenya, Kaposi Sarcoma (KS) is one of the most common cancers and a leading cause of cancer-related deaths in men. However, tracking how well patients are responding to treatment is challenging, especially in busy clinics. Doctors must measure the size and changes in the areas affected by the cancer by hand, which can take a lot of time and can vary depending on the doctor. This method does not work well for patients with dark skin, which can lead to biases in treatment compared to patients with fairer skin.
To solve this problem, the in...